Further analyses with a larger cohort, as well as a longer clinical follow-up to verify if and when MCI and in particular, MCI carrying FCGRIIB TT genotype, will develop AD, and if the correlation with IgG3 in these converted patients remains significant, will be necessary to further confirm these data. This evidence concerns the gene IGHG3 and Alzheimer disease.